Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.42 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.35 |
| ▸ | IGF2R | P11717 | 4/20 | 0.33 |
| ▸ | PGD | P52209 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12128761 | 0.93 | FBP1 (0.33) | FBP1 | |
| SCHEMBL13882144 | 0.89 | FBP1 (0.31) | FBP1 | |
| SCHEMBL20465720 | 0.88 | — | — | |
| SCHEMBL25572013 | 0.88 | — | — | |
| SCHEMBL24814865 | 0.85 | FBP1 (0.36) | FBP1AMDHD2PGD | |
| SCHEMBL13521263 | 0.84 | — | — | |
| SCHEMBL25553231 | 0.82 | — | — | |
| SCHEMBL27282033 | 0.79 | SMPD1 (0.37) | FBP1 | |
| SCHEMBL19760163 | 0.79 | FBP1 (0.61) | FBP1AMDHD2IGF2R | |
| SCHEMBL17052655 | 0.77 | TLR4 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265438-A1 | NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF CNNM4 IN A CELL | ASOCIACION CENTRO DE INVESTIG COOPERATIVA EN BIOCIENCIAS CIC BIOGUNE (ES) | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265438-A1 | NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF CNNM4 IN A CELL | HNF4A, CDK4, CDKL4 | FBP1 1806/4885AMDHD2 1256/4885IGF2R 1110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.